New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2014
07:52 EDTORAN, SNY, SLBWestern companies may seek return to Iran as sanctions ease, WSJ says
Temporary sanctions relief hasn't yet translated into an economic turnaround in Iran, but a steady flow of executives in recent weeks signals that some companies that previously did business there, such as Schlumberger (SLB), Sanofi (SNY), and Orange (ORAN), may be interested in exploring a return, according to The Wall Street Journal. Reference Link
News For ORAN;SNY;SLB From The Last 14 Days
Check below for free stories on ORAN;SNY;SLB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
07:40 EDTSLBUBS to hold a conference
Houston Energy Bus-less Tour is being held in Houston on September 17-19 with webcasted company presentations to begin on September 17 at 8:30 am; not all company presentations may be webcasted. Webcast Link
07:27 EDTORANJazztel investor won't sell stake to Orange for proposed price, Reuters says
Subscribe for More Information
06:18 EDTSNYSanofi, MyoKardia announce collaboration
Subscribe for More Information
September 16, 2014
15:59 EDTORANVodafone, EE in talks to acquire Phones 4U assets, FT reports
Subscribe for More Information
09:25 EDTORANOn The Fly: Pre-market Movers
Subscribe for More Information
07:42 EDTSLBDeutsche Bank to hold a conference
Subscribe for More Information
07:33 EDTSNYMylan initiates Phase III clinical trials for Advair Diskus and Lantus
Mylan (MYL) announced it is initiating Phase III clinical trials for its generic version of GlaxoSmithKline's (GKS) Advair Diskus and its insulin analog to Sanofi's (SNY) Lantus. In October Mylan will commence a Phase III clinical trial to evaluate the equivalence of its product to Advair Diskus when administered by inhalation in adult asthma patients.
September 15, 2014
17:42 EDTORANOrange SA bids $4.4B for broadband carrier Jazztel, Bloomberg says
Subscribe for More Information
17:00 EDTORANOrange SA to offer EU13/share in cash for Jazztel, Bloomberg says
Subscribe for More Information
12:03 EDTORANOrange close to deal to buy Jazztel for EUR3B, FT reports
Subscribe for More Information
07:24 EDTORANCredit Suisse to hold a conference
Subscribe for More Information
07:23 EDTSLBHart Energy to hold a conference
2014 DUG Eagle Ford Conference to be held in San Antonio, California on September 15-17.
07:11 EDTORANVodafone says Phones 4u situation 'incorrectly' handled, WSJ says
Vodafone (VOD) said that its choice to end its 15-year collaboration with Phones 4u was "incorrectly" dealt with and the company did not allot enough time to finalize a commercial resolution, according to The Wall Street Journal, citing comments from a Vodafone spokesman. A joint venture between Deutsche Telecom (DTEGY) and Orange (ORAN), EE, also ended its contract with Phones 4u next September. Reference Link
September 12, 2014
15:48 EDTSLBSchlumberger favored to win Petrobras service contract, Bloomberg reports
Schlumberger (SLB) is favored to win half of the well services work being offered by Petrobras (PZE) which is valued at more than $2B, Bloomberg says, citing two people with knowledge of the tender. Schlumberger had submitted the most competitive bid for 50% of the well services work, Halliburton (HAL) had placed the lowest-cost bid for 30% of the work, and Baker Hughes (BHI) is set to win the remaining 20% of the work, the people added. Reference Link
10:04 EDTSNYSanofi unit granted orphan status for treatment of Gaucher disease
Subscribe for More Information
September 11, 2014
05:27 EDTSNYGenzyme announces positive interim results from Lemtrada extension study
Subscribe for More Information
September 10, 2014
07:09 EDTSNYAmericas Committee for Treatment & Research in MS to hold a meeting
Subscribe for More Information
September 8, 2014
14:16 EDTSNYSanofi announces FDA approval of Menactra vaccine
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use